Form 4: Lantheus Holdings Chief Accounting Officer Andrea Sabens Sells Shares Under 10b5-1 Plan

Sentiment:

SEC Form 4 Filing


Andrea Sabens, Chief Accounting Officer of Lantheus Holdings, sold 341 shares of common stock at $60.48 per share on March 13, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Summary

  • On March 13, 2024, Andrea Sabens, the Chief Accounting Officer of Lantheus Holdings, Inc., sold 341 shares of common stock.
  • The sale was executed at a price of $60.48 per share.
  • The transaction was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2023.
  • Following the transaction, Andrea Sabens directly owns 63,204 shares of Lantheus Holdings, Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider transaction. It doesn't inherently convey positive or negative sentiment about the company's performance or prospects.

Future Outlook

There is no future outlook provided in this document.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is important for investors to assess management's perspective on the company's value and prospects. The use of a 10b5-1 plan indicates that the trading was pre-planned and not based on any specific non-public information at the time of the transaction.

Comparison to Industry Standards

  • Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
  • The use of a 10b5-1 trading plan is a common method for corporate insiders to sell shares without raising concerns about trading on non-public information, aligning with best practices in corporate governance.
  • Comparable companies like GE Healthcare, Siemens Healthineers, and Philips also have similar insider trading policies and reporting requirements.

Stakeholder Impact

  • The sale of shares by a company executive may have a minor psychological impact on shareholders, but the use of a pre-arranged trading plan mitigates concerns about insider information.

Key Dates

DateDescription
2023-08-11Date of adoption of Rule 10b5-1 trading plan
2024-03-13Date of transaction (sale of shares)
2024-03-15Date of signature on the Form 4 filing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.